Published in Am J Bioeth on May 01, 2007
Obtaining consent for future research with induced pluripotent cells: opportunities and challenges. PLoS Biol (2009) 1.58
Ethical issues in stem cell research. Endocr Rev (2009) 1.20
Thinking about the human neuron mouse. Am J Bioeth (2007) 6.98
Further thoughts about the human neuron mouse. Am J Bioeth (2007) 0.86
The ethical mouse: be not like Icarus. Am J Bioeth (2007) 0.85
Part-human chimeras: worrying the facts, probing the ethics. Am J Bioeth (2007) 0.85
Beyond the human neuron mouse to the NAS Guidelines. Am J Bioeth (2007) 0.84
Creating non-human persons: might it be worth the risk? Am J Bioeth (2007) 0.84
Of mice and men. Am J Bioeth (2007) 0.84
The moral musings of a murine chimera. Am J Bioeth (2007) 0.83
Managing incidental findings in human subjects research: analysis and recommendations. J Law Med Ethics (2008) 12.10
Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65
Thinking about the human neuron mouse. Am J Bioeth (2007) 6.98
Patient Perspectives on the Learning Health System: The Importance of Trust and Shared Decision Making. Am J Bioeth (2015) 5.07
Research ethics and the challenge of whole-genome sequencing. Nat Rev Genet (2008) 4.03
Attitudes Toward Risk and Informed Consent for Research on Medical Practices: A Cross-sectional Survey. Ann Intern Med (2015) 3.71
Medicine. The future of personal genomics. Science (2007) 3.36
Ethics. Incidental findings in brain imaging research. Science (2006) 3.10
Diagnostic testing fails the test. Nature (2002) 2.66
Genetic research and health disparities. JAMA (2004) 2.24
Commercial landscape of noninvasive prenatal testing in the United States. Prenat Diagn (2013) 2.03
Financial conflict-of-interest policies in clinical research: issues for clinical investigators. Acad Med (2003) 1.84
Protecting subjects' interests in genetics research. Am J Hum Genet (2002) 1.45
Genetics. Toward a new vocabulary of human genetic variation. Science (2002) 1.44
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol (2013) 1.33
What is in a cause? Exploring the relationship between genetic cause and felt stigma. Genet Med (2006) 1.23
Ethical implications of array comparative genomic hybridization in complex phenotypes: points to consider in research. Genet Med (2007) 1.16
Medical and graduate students' attitudes toward personal genomics. Genet Med (2011) 1.14
A pilot survey on the licensing of DNA inventions. J Law Med Ethics (2003) 1.13
Research ethics in the era of personalized medicine: updating science's contract with society. Public Health Genomics (2010) 1.11
Biomedical scientists' perceptions of ethical and social implications: is there a role for research ethics consultation? PLoS One (2009) 1.11
Genetics. DNA patenting and licensing. Science (2002) 1.09
Cell-free fetal nucleic acid testing: a review of the technology and its applications. Obstet Gynecol Surv (2011) 1.07
Innocent fun or "microslavery"? An ethical analysis of biotic games. Hastings Cent Rep (2014) 1.05
Ethics. Issues in oocyte donation for stem cell research. Science (2005) 1.01
Race and ethnicity in genetic research. Am J Med Genet A (2007) 1.01
Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn (2011) 1.01
Secondary researchers' duties to return incidental findings and individual research results: a partial-entrustment account. Genet Med (2012) 1.00
ELSI priorities for brain imaging. Am J Bioeth (2006) 0.98
Triggers for research ethics consultation. Sci Transl Med (2012) 0.96
The Henrietta Lacks legacy grows. EMBO Rep (2013) 0.96
Privacy issues in personalized medicine. Pharmacogenomics (2003) 0.92
Views of genetics health professionals on the return of genomic results. J Genet Couns (2013) 0.91
What are gene patents and why are people worried about them? Community Genet (2005) 0.91
Customers or research participants? Guidance for research practices in commercialization of personal genomics. Genet Med (2012) 0.91
Human evolutionary genomics: ethical and interpretive issues. Trends Genet (2012) 0.89
Genetic counseling for prenatal testing: where is the discussion about disability? J Genet Couns (2012) 0.88
Awareness and Acceptable Practices: IRB and Researcher Reflections on the Havasupai Lawsuit. AJOB Prim Res (2013) 0.87
Direct-to-consumer genetic tests: beyond medical regulation? Genome Med (2009) 0.87
Recommendations for nanomedicine human subjects research oversight: an evolutionary approach for an emerging field. J Law Med Ethics (2012) 0.87
Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context. Hum Reprod (2012) 0.83
In the public interest? Sci Transl Med (2012) 0.82
Ethical, legal, social, and policy implications of behavioral genetics. Annu Rev Genomics Hum Genet (2013) 0.81
Demographic and experiential correlates of public attitudes towards cell-free fetal DNA screening. J Genet Couns (2014) 0.81
Translating cell-free fetal DNA technology: structural lessons from non-invasive RhD blood typing. Trends Biotechnol (2012) 0.80
Cellular therapies for heart disease: unveiling the ethical and public policy challenges. J Mol Cell Cardiol (2007) 0.77
Interest, rationale, and potential clinical applications of genetic testing for mood disorders: a survey of stakeholders. J Affect Disord (2012) 0.76
Informed Consent for Research on Medical Practices. Ann Intern Med (2015) 0.76
Genetic testing of children for predisposition to mood disorders: anticipating the clinical issues. J Genet Couns (2014) 0.76
Informational risk, institutional review, and autonomy in the proposed changes to the common rule. IRB (2012) 0.76
Adrift in the Gray Zone: IRB Perspectives on Research in the Learning Health System. AJOB Empir Bioeth (2016) 0.75
Industry opposes genomic legislation. Nat Biotechnol (2002) 0.75
Introduction: jurisdictions of authority and expertise in science and medicine. Med Anthropol (2002) 0.75
A commentary on oocyte donation for stem cell research in South Korea. Am J Bioeth (2006) 0.75
Ethics watch: the G.I. genome: ethical implications of genome sequencing in the military. Nat Rev Genet (2011) 0.75
Are clinical trials of cell transplantation for Duchenne muscular dystrophy ethical? IRB (1994) 0.75